Inventor · disambiguated record
Michael C. Jaye
Also filed as: JAYE MICHAEL · JAYE MICHAEL C
18 granted patents·4 pending applications·404 citations·filing 1986–2011
95Inventor score
Files withRHONE POULENC RORER PHARMA7AVENTIS PHARMA INC6JAYE MICHAEL2AVENTIS PHARM PROD INC1OSTEOSA INC1
Top patents by PatentIndex Score
22 records- 0189US5656598AUse of fibroblast growth factors to stimulate bone growthRHONE POULENC RORER PHARMA·Filed 1995·Granted Aug 12, 1997·89 cites·37 claims
- 0285US4868113ARecombinant DNA vector encoding human endothelial cell growth factorRORER BIOTECHNOLOGY·Filed 1986·Granted Sep 19, 1989·47 cites·22 claims
- 0381US5614496AUse of fibroblast growth factors to stimulate bone growthOSTEOSA INC·Filed 1995·Granted Mar 25, 1997·59 cites·17 claims
- 0479US7056720B2LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapiesAVENTIS PHARMA INC·Filed 2002·Granted Jun 6, 2006·8 cites·9 claims
- 0579US5863888AHuman Bek Fibroblast growth factor receptorRHONE POULENC RORER PHARMA·Filed 1995·Granted Jan 26, 1999·37 cites·9 claims
- 0678US5541109AExpression cloning of c-src SH3-domain binding proteinsRHONE POULENC RORER PHARMA·Filed 1994·Granted Jul 30, 1996·54 cites·18 claims
- 0773US6344546B1Fibroblast growth factor receptorsRHONE POULENC RORER INC·Filed 1994·Granted Feb 5, 2002·40 cites·5 claims
- 0872USRE38240EDNA encoding human endothelial cell growth factors and plasmids comprising said DNAAVENTIS PHARMA INC·Filed 2000·Granted Aug 26, 2003·1 cites·29 claims
- 0969US8343494B2Antibodies against LLG polypeptides of the triacylglycerol lipase familyAVENTIS PHARMA INC·Filed 2009·Granted Jan 1, 2013·0 cites·4 claims
- 1064US7008776B1Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein AI very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterolUNIV PENNSYLVANIA·Filed 1999·Granted Mar 7, 2006·15 cites·2 claims
- 1162US2009208479A1Compositions and Methods for Effecting the Levels of High Density Lipoprotein (HDL) Cholesterol and Apolipoprotein AI, Very Low Density Lipoprotein (VLDL) Cholesterol and Low Density Lipoprotein (LDL) CholesterolJAYE MICHAEL·Filed 2008·Application pending·0 cites
- 1256US7579447B2Antibodies against LLG polypeptides of the triacylglycerol lipase familyAVENTIS PHARMA INC·Filed 2006·Granted Aug 25, 2009·0 cites·7 claims
- 1356US5270452APure glia maturation factorRHONE POULENC RORER PHARMA·Filed 1991·Granted Dec 14, 1993·18 cites·13 claims
- 1456US2006088504A1Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein Al, very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterolAVENTIS PHARMA INC·Filed 2005·Application pending·0 cites
- 1554US6395530B1LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapiesAVENTIS PHARMA INC·Filed 1997·Granted May 28, 2002·11 cites·18 claims
- 1653US2013059361A1Compositions and Methods for Effecting the Levels of High Density Lipoprotein (HDL) Cholesterol and Apolipoprotein AI, Very Low Density Lipoprotein (VLDL) Cholesterol and Low Density Lipoprotein (LDL) CholesterolJAYE MICHAEL·Filed 2011·Application pending·0 cites
- 1747US4861710ARecombinant DNA clone encoding laminin receptorUS HEALTH·Filed 1986·Granted Aug 29, 1989·8 cites·19 claims
- 1844US5827826ACompositions of human endothelial cell growth factorRHONE POULENC RORER PHARMA·Filed 1996·Granted Oct 27, 1998·7 cites·10 claims
- 1943US5571790ARecombinant human endothelial cell growth factorRHONE POULENC RORER PHARMA·Filed 1995·Granted Nov 5, 1996·7 cites·12 claims
- 2039US5849538ADNA encoding human endothelial cell growth factors and plasmids comprising said DNARHONE POULENC RORER PHARMA·Filed 1997·Granted Dec 15, 1998·3 cites·13 claims
- 2137US2003220373A1Therapeutic uses of PPAR mediatorsFiled 2002·Application pending·0 cites
- 2232USRE37850ERecombinant human endothelial cell growth factorAVENTIS PHARM PROD INC·Filed 2000·Granted Sep 17, 2002·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Michael C. Jaye files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →